United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded May 28, 2026 · Filed May 29, 2026

On May 28, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$565.64 for US$5.37M under a trading plan, leaving 40,513 shares. Filed May 29, 2026 (Form 4).

Sold
9,500 shares
Price
US$565.64 average (US$561.53 to US$571.55)
Value
US$5.37M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 28, 2026Common StockOption exercise9,500US$146.0350,013Direct
May 28, 2026Common StockSale295US$561.5349,718Direct
May 28, 2026Common StockSale1,520US$562.5948,198Direct
May 28, 2026Common StockSale1,638US$563.6846,560Direct
May 28, 2026Common StockSale1,369US$564.5945,191Direct
May 28, 2026Common StockSale563US$565.6944,628Direct
May 28, 2026Common StockSale1,261US$566.7243,367Direct
May 28, 2026Common StockSale1,339US$567.7642,028Direct
May 28, 2026Common StockSale728US$568.7841,300Direct
May 28, 2026Common StockSale227US$569.5741,073Direct
May 28, 2026Common StockSale260US$570.7640,813Direct
May 28, 2026Common StockSale300US$571.5540,513Direct

Source

View original at SEC

Related